AMARIN CORP PLC\UK Other Tax Expense (Benefit)
AMARIN CORP PLC\UK (AMRN) reported Other Tax Expense (Benefit) of -$1.30 million for the 12-month period ending 2015-12-31, per its 10-K filed 2016-02-25.
Discontinued › Expense Statement › Income Tax
us-gaap:OtherTaxExpenseBenefit · last filed 2016-02-25
- AMARIN CORP PLC\UK other tax expense (benefit) for fiscal 2015 was -$1.30M, a 192.86% decline from fiscal 2014.
- AMARIN CORP PLC\UK other tax expense (benefit) for fiscal 2014 was $1.40M, a 26.32% decline from fiscal 2013.
- AMARIN CORP PLC\UK other tax expense (benefit) for fiscal 2013 was $1.90M, a 90.00% increase from fiscal 2012.
- AMARIN CORP PLC\UK other tax expense (benefit) for fiscal 2012 was $1.00M.
| Period end | Other Tax Expense (Benefit) 12 month |
|---|---|
| 2015-12-31 | -$1.30M 10-K · filed 2016-02-25 |
| 2014-12-31 | $1.40M 10-K · filed 2015-03-03 |
| 2013-12-31 | $1.90M 10-K · filed 2014-02-27 |
| 2012-12-31 | $1.00M 10-K · filed 2013-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B |